• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从海量公开转录组测序数据中系统地鉴定内含子保留相关变异。

Systematic identification of intron retention associated variants from massive publicly available transcriptome sequencing data.

机构信息

Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo, Japan.

Cancer RNA Research Unit, National Cancer Center Research Institute, Tokyo, Japan.

出版信息

Nat Commun. 2022 Sep 29;13(1):5357. doi: 10.1038/s41467-022-32887-9.

DOI:10.1038/s41467-022-32887-9
PMID:36175409
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9522810/
Abstract

Many disease-associated genomic variants disrupt gene function through abnormal splicing. With the advancement of genomic medicine, identifying disease-associated splicing associated variants has become more important than ever. Most bioinformatics approaches to detect splicing associated variants require both genome and transcriptomic data. However, there are not many datasets where both of them are available. In this study, we develop a methodology to detect genomic variants that cause splicing changes (more specifically, intron retention), using transcriptome sequencing data alone. After evaluating its sensitivity and precision, we apply it to 230,988 transcriptome sequencing data from the publicly available repository and identified 27,049 intron retention associated variants (IRAVs). In addition, by exploring positional relationships with variants registered in existing disease databases, we extract 3,000 putative disease-associated IRAVs, which range from cancer drivers to variants linked with autosomal recessive disorders. The in-silico screening framework demonstrates the possibility of near-automatically acquiring medical knowledge, making the most of massively accumulated publicly available sequencing data. Collections of IRAVs identified in this study are available through IRAVDB ( https://iravdb.io/ ).

摘要

许多与疾病相关的基因组变异通过异常剪接破坏基因功能。随着基因组医学的进步,鉴定与剪接相关的疾病相关变异变得比以往任何时候都更加重要。大多数用于检测剪接相关变异的生物信息学方法都需要基因组和转录组数据。然而,有很多数据集同时提供这两种数据。在这项研究中,我们开发了一种仅使用转录组测序数据检测导致剪接变化(更具体地说是内含子保留)的基因组变异的方法。在评估其灵敏度和精度后,我们将其应用于来自公开存储库的 230988 个转录组测序数据,并鉴定出 27049 个内含子保留相关变异(IRAV)。此外,通过探索与现有疾病数据库中注册的变异的位置关系,我们提取了 3000 个潜在的与疾病相关的 IRAV,其中包括癌症驱动因子和与常染色体隐性疾病相关的变异。该计算筛选框架展示了充分利用大量积累的公开可用测序数据自动获取医学知识的可能性。本研究中鉴定的 IRAV 集合可通过 IRAVDB(https://iravdb.io/)获得。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e933/9522810/b191d0a1278a/41467_2022_32887_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e933/9522810/6bb9fadf7c45/41467_2022_32887_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e933/9522810/82ee4d62bd5b/41467_2022_32887_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e933/9522810/326709193252/41467_2022_32887_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e933/9522810/013e48a2cc16/41467_2022_32887_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e933/9522810/8f40354998fc/41467_2022_32887_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e933/9522810/b191d0a1278a/41467_2022_32887_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e933/9522810/6bb9fadf7c45/41467_2022_32887_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e933/9522810/82ee4d62bd5b/41467_2022_32887_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e933/9522810/326709193252/41467_2022_32887_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e933/9522810/013e48a2cc16/41467_2022_32887_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e933/9522810/8f40354998fc/41467_2022_32887_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e933/9522810/b191d0a1278a/41467_2022_32887_Fig6_HTML.jpg

相似文献

1
Systematic identification of intron retention associated variants from massive publicly available transcriptome sequencing data.从海量公开转录组测序数据中系统地鉴定内含子保留相关变异。
Nat Commun. 2022 Sep 29;13(1):5357. doi: 10.1038/s41467-022-32887-9.
2
SNPlice: variants that modulate Intron retention from RNA-sequencing data.SNPlice:从RNA测序数据中调控内含子保留的变异体。
Bioinformatics. 2015 Apr 15;31(8):1191-8. doi: 10.1093/bioinformatics/btu804. Epub 2014 Dec 6.
3
RNA sequencing and target long-read sequencing reveal an intronic transposon insertion causing aberrant splicing.RNA测序和靶向长读长测序揭示了一个内含子转座子插入导致异常剪接。
J Hum Genet. 2024 Feb;69(2):91-99. doi: 10.1038/s10038-023-01211-8. Epub 2023 Dec 15.
4
New insights into minor splicing-a transcriptomic analysis of cells derived from TALS patients.TALS 患者来源细胞的转录组分析揭示剪接的新见解
RNA. 2019 Sep;25(9):1130-1149. doi: 10.1261/rna.071423.119. Epub 2019 Jun 7.
5
Identification of Synonymous Pathogenic Variants in Monogenic Disorders by Integrating Exome with Transcriptome Sequencing.通过外显子组与转录组测序整合鉴定单基因疾病中的同义致病性变异。
J Mol Diagn. 2024 Apr;26(4):267-277. doi: 10.1016/j.jmoldx.2023.12.005. Epub 2024 Jan 26.
6
Intron retention is a widespread mechanism of tumor-suppressor inactivation.内含子保留是肿瘤抑制因子失活的一种广泛机制。
Nat Genet. 2015 Nov;47(11):1242-8. doi: 10.1038/ng.3414. Epub 2015 Oct 5.
7
Effectiveness of integrated interpretation of exome and corresponding transcriptome data for detecting splicing variants of genes associated with autosomal recessive disorders.外显子组与相应转录组数据综合解读在检测常染色体隐性遗传病相关基因剪接变异中的有效性
Mol Genet Metab Rep. 2019 Oct 23;21:100531. doi: 10.1016/j.ymgmr.2019.100531. eCollection 2019 Dec.
8
Intronic position +9 and -9 are potentially splicing sites boundary from intronic variants analysis of whole exome sequencing data.内含子位置+9 和-9 是从外显子组测序数据的内含子变体分析中潜在的剪接位点边界。
BMC Med Genomics. 2023 Jun 26;16(1):146. doi: 10.1186/s12920-023-01542-7.
9
Minor intron splicing revisited: identification of new minor intron-containing genes and tissue-dependent retention and alternative splicing of minor introns.重新审视次要内含子剪接:新的包含次要内含子的基因的鉴定以及次要内含子的组织依赖性保留和可变剪接。
BMC Genomics. 2019 Aug 30;20(1):686. doi: 10.1186/s12864-019-6046-x.
10
Improved detection of aberrant splicing with FRASER 2.0 and the intron Jaccard index.FRASER 2.0 和内含子 Jaccard 指数可提高异常剪接的检测能力。
Am J Hum Genet. 2023 Dec 7;110(12):2056-2067. doi: 10.1016/j.ajhg.2023.10.014. Epub 2023 Nov 24.

引用本文的文献

1
Intron Retention: A Reemerging Paradigm in RNA Biology and Post-Transcriptional Gene Regulation.内含子保留:RNA生物学和转录后基因调控中重新出现的范式
Genes (Basel). 2025 Aug 21;16(8):986. doi: 10.3390/genes16080986.
2
Cross-attention graph neural networks for inferring gene regulatory networks with skewed degree distribution.用于推断具有偏态度分布的基因调控网络的交叉注意力图神经网络。
BMC Bioinformatics. 2025 Jul 16;26(1):179. doi: 10.1186/s12859-025-06186-1.
3
Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric CNS tumors.

本文引用的文献

1
RNA splicing analysis using heterogeneous and large RNA-seq datasets.使用异质和大型 RNA-seq 数据集进行 RNA 剪接分析。
Nat Commun. 2023 Mar 3;14(1):1230. doi: 10.1038/s41467-023-36585-y.
2
High-coverage whole-genome sequencing of the expanded 1000 Genomes Project cohort including 602 trios.对扩展的 1000 基因组项目队列进行高覆盖率全基因组测序,包括 602 个三核苷酸重复序列。
Cell. 2022 Sep 1;185(18):3426-3440.e19. doi: 10.1016/j.cell.2022.08.004.
3
recount3: summaries and queries for large-scale RNA-seq expression and splicing.recount3:大规模 RNA-seq 表达和剪接的摘要和查询。
生殖系致病变异影响小儿中枢神经系统肿瘤的体细胞改变和患者预后。
medRxiv. 2025 Feb 6:2025.02.04.25321499. doi: 10.1101/2025.02.04.25321499.
4
Systematically developing a registry of splice-site creating variants utilizing massive publicly available transcriptome sequence data.利用大量公开的转录组序列数据系统地建立一个剪接位点创建变体的登记册。
Nat Commun. 2025 Jan 9;16(1):426. doi: 10.1038/s41467-024-55185-y.
5
Clinical and Molecular Characterization of Splicing Variants in Patients with Juvenile Polyposis Syndrome.《青少年息肉综合征患者剪接变异的临床和分子特征》
Int J Mol Sci. 2024 Jul 20;25(14):7939. doi: 10.3390/ijms25147939.
6
A single-cell strategy for the identification of intronic variants related to mis-splicing in pancreatic cancer.一种用于鉴定与胰腺癌错配剪接相关内含子变异的单细胞策略。
NAR Genom Bioinform. 2024 May 25;6(2):lqae057. doi: 10.1093/nargab/lqae057. eCollection 2024 Jun.
7
Comprehensive profiling of cancer neoantigens from aberrant RNA splicing.从异常 RNA 剪接中全面分析癌症新抗原。
J Immunother Cancer. 2024 May 15;12(5):e008988. doi: 10.1136/jitc-2024-008988.
8
Assessing the efficacy of target adaptive sampling long-read sequencing through hereditary cancer patient genomes.通过遗传性癌症患者基因组评估靶向适应性采样长读长测序的功效。
NPJ Genom Med. 2024 Feb 17;9(1):11. doi: 10.1038/s41525-024-00394-z.
9
RNA Sequencing in Disease Diagnosis.RNA 测序在疾病诊断中的应用。
Annu Rev Genomics Hum Genet. 2024 Aug;25(1):353-367. doi: 10.1146/annurev-genom-021623-121812. Epub 2024 Aug 6.
10
Association of Genetic Markers with the Risk of Early-Onset Breast Cancer in Kazakh Women.遗传标记物与哈萨克族妇女早发性乳腺癌风险的关联。
Genes (Basel). 2024 Jan 17;15(1):108. doi: 10.3390/genes15010108.
Genome Biol. 2021 Nov 29;22(1):323. doi: 10.1186/s13059-021-02533-6.
4
ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG).美国医学遗传学与基因组学学会(ACMG)关于临床外显子组和基因组测序中次要发现报告的ACMG SF v3.0清单:一项政策声明
Genet Med. 2021 Aug;23(8):1381-1390. doi: 10.1038/s41436-021-01172-3. Epub 2021 May 20.
5
Breast Cancer Patient Prognosis Is Determined by the Interplay between Mutation and Alternative Transcript Expression: Insights from Long Amplicon Digital PCR Assays.乳腺癌患者的预后由突变与可变转录本表达之间的相互作用决定:来自长扩增子数字PCR分析的见解。
Cancers (Basel). 2021 Mar 26;13(7):1531. doi: 10.3390/cancers13071531.
6
To NMD or Not To NMD: Nonsense-Mediated mRNA Decay in Cancer and Other Genetic Diseases.是否存在 NMD:癌症和其他遗传疾病中的无意义介导的 mRNA 降解。
Trends Genet. 2021 Jul;37(7):657-668. doi: 10.1016/j.tig.2020.11.002. Epub 2020 Dec 2.
7
Discovery of driver non-coding splice-site-creating mutations in cancer.在癌症中发现驱动性非编码剪接位点创造突变。
Nat Commun. 2020 Nov 4;11(1):5573. doi: 10.1038/s41467-020-19307-6.
8
The mutational constraint spectrum quantified from variation in 141,456 humans.从 141456 名人类个体的变异中量化的突变约束谱。
Nature. 2020 May;581(7809):434-443. doi: 10.1038/s41586-020-2308-7. Epub 2020 May 27.
9
Genomic basis for RNA alterations in cancer.癌症中 RNA 改变的基因组基础。
Nature. 2020 Feb;578(7793):129-136. doi: 10.1038/s41586-020-1970-0. Epub 2020 Feb 5.
10
The impact of nonsense-mediated mRNA decay on genetic disease, gene editing and cancer immunotherapy.无义介导的 mRNA 衰变对遗传疾病、基因编辑和癌症免疫治疗的影响。
Nat Genet. 2019 Nov;51(11):1645-1651. doi: 10.1038/s41588-019-0517-5. Epub 2019 Oct 28.